The AUA has released its first clinical guideline on the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).
The AUA has released its first clinical guideline on the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).
The new guideline is designed to present a clinical strategy for physicians, and the guideline panel notes that the most effective approach for a specific case should be determined by individual patients and their clinician.
Panel experts recommend the following assessments for both women and men:
The panel outlines the following key clinical principles for first-line treatment:
"IC/BPS affects a significant number of patients whose quality of life is severely diminished by this complicated, frustrating condition," said Philip M. Hanno, MD, MPH, of the University of Pennsylvania, Philadelphia, who chaired the multidisciplinary panel that developed the guideline. "This population has historically been both under-recognized and underserved, and it is our hope that this guideline provides physicians with a much-needed roadmap to help treat these patients."
A complete executive summary of the guideline will be published in an upcoming issue of the Journal of Urology, and a Webinar about the guideline will also be made available online at www.AUAnet.org. Look for a more detailed report on the guideline in an upcoming issue of Urology Times.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.